MOUHAMMED A HABRA to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications MOUHAMMED A HABRA has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
0.026
-
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring. J Clin Endocrinol Metab. 2013 Jan; 98(1):31-42.
Score: 0.026
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.